Picket pharmaceuticals
Develops and brings to market innovative complex generic pharmaceutical products across a range of therapeutic areas.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | - | ||
| Total Funding | 000k | ||
Related Content
Picket Pharmaceuticals is a privately held pharmaceutical manufacturer based in the United States, specializing in the development and commercialization of generic pharmaceutical products. The company targets products that are clinically essential, at risk for under supply, and have seen price increases. Picket Pharmaceuticals emphasizes quality systems that support both internal activities and supply chain participants, ensuring dependability on quality, availability, and price.
The company operates in the pharmaceutical industry, primarily serving healthcare providers, pharmacies, and patients who require access to essential medications. Picket Pharmaceuticals focuses on technologically challenging small molecule drugs, leveraging manufacturing and regulatory advances to bring new products to market efficiently. The business model revolves around identifying and addressing gaps in the supply of critical medications, thereby improving health and wellbeing.
Revenue is generated through the sale of its generic pharmaceutical products, which are developed to meet ongoing clinical needs and are often granted FDA authorization due to the company's disciplined approach. By targeting 35 product groupings with a shortened timeline to market approval of 18 months, Picket Pharmaceuticals aims to provide reliable access to high-quality medications.
Keywords: generic pharmaceuticals, clinical needs, quality systems, supply chain, small molecule drugs, FDA authorization, healthcare providers, pharmacies, essential medications, market approval.